Literature DB >> 25761379

Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity.

Alessandra Marengoni1, Graziano Onder2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25761379     DOI： 10.1136/bmj.h1059

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  45 in total

1.  A Comparative Study of Carvedilol Versus Metoprolol Initiation and 1-Year Mortality Among Individuals Receiving Maintenance Hemodialysis.

Authors:  Magdalene M Assimon; M Alan Brookhart; Jason P Fine; Gerardo Heiss; J Bradley Layton; Jennifer E Flythe
Journal:  Am J Kidney Dis       Date:  2018-04-10       Impact factor: 8.860

2.  Multimorbidity: what next?

Authors:  Frances S Mair; Katie I Gallacher
Journal:  Br J Gen Pract       Date:  2017-06       Impact factor: 5.386

3.  Introducing pharmacogenetic testing with clinical decision support into primary care: a feasibility study.

Authors:  Martin Dawes; Martin N Aloise; J Sidney Ang; Pieter Cullis; Diana Dawes; Robert Fraser; Gideon Liknaitzky; Andrea Paterson; Paul Stanley; Adriana Suarez-Gonzalez; Hagit Katzov-Eckert
Journal:  CMAJ Open       Date:  2016-09-21

Review 4.  Polypharmacy-an Upward Trend with Unpredictable Effects.

Authors:  Dirk Moßhammer; Hannah Haumann; Klaus Mörike; Stefanie Joos
Journal:  Dtsch Arztebl Int       Date:  2016-09-23       Impact factor: 5.594

5.  Development and validation of the Cambridge Multimorbidity Score.

Authors:  Rupert A Payne; Silvia C Mendonca; Marc N Elliott; Catherine L Saunders; Duncan A Edwards; Martin Marshall; Martin Roland
Journal:  CMAJ       Date:  2020-02-03       Impact factor: 8.262

6.  Polypharmacotherapy and blood products as risk factors for venous thromboembolism in postsurgical patients: a case-control study.

Authors:  Alenka Premuš Marušič; Daniel Petrovič; Aleš Mrhar; Igor Locatelli
Journal:  Int J Clin Pharm       Date:  2017-03-09

7.  Health care professionals' attitudes towards deprescribing in older patients with limited life expectancy: A systematic review.

Authors:  Carina Lundby; Trine Graabaek; Jesper Ryg; Jens Søndergaard; Anton Pottegård; Dorthe Susanne Nielsen
Journal:  Br J Clin Pharmacol       Date:  2019-02-27       Impact factor: 4.335

Review 8.  Multimorbidity and functional impairment-bidirectional interplay, synergistic effects and common pathways.

Authors:  A Calderón-Larrañaga; D L Vetrano; L Ferrucci; S W Mercer; A Marengoni; G Onder; M Eriksdotter; L Fratiglioni
Journal:  J Intern Med       Date:  2018-11-22       Impact factor: 8.989

9.  Strategies to Improve Medication Adherence in Older Persons: Consensus Statement from the Senior Italia Federanziani Advisory Board.

Authors:  Alessandra Marengoni; Alessandro Monaco; Elisio Costa; Antonio Cherubini; Alexandra Prados-Torres; Christiane Muth; Renè J F Melis; Luca Pasina; Tischa J M van der Cammen; Katie Palmer; Sergio Pecorelli; Graziano Onder
Journal:  Drugs Aging       Date:  2016-09       Impact factor: 3.923

10.  Clinically important drug-drug interactions in poly-treated elderly outpatients: a campaign to improve appropriateness in general practice.

Authors:  Emanuel Raschi; Carlo Piccinni; Vincenzo Signoretta; Lucio Lionello; Silvia Bonezzi; Marcello Delfino; Lucia Di Candia; Lucio Di Castri; Fabio Pieraccini; Daniela Carati; Elisabetta Poluzzi; Fabrizio De Ponti
Journal:  Br J Clin Pharmacol       Date:  2015-11-12       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.